Gaudium IVF and Women Health Ltd.

•

gaudiumivfcentre.comBSE: 544709NSE: GAUDIUMIVF

Market Cap₹ 900 Cr.

Current Price

High / Low₹ 163 / 69

Stock P/E40.4

Book Value₹ 21

Price to Book5.65

Dividend Yield0.00 %

ROCE49.3 %

ROE51.6 %

Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has a good return on equity (ROE) track record: 3 Years ROE 57.9%
Company has a healthy return on capital (ROCE) of 57.1%
Latest quarter profit grew 157.9% YoY, showing strong momentum
Operating margins have improved to 47.6% from 37.8%
Company comfortably covers its interest (16.2x coverage)
Company maintains a comfortable, low leverage position

CONS

Receivables are growing faster than sales - a possible quality concern
Debtor days have increased from 58 to 115

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	APOLLOHOSP	8715.00	59.97	125308.33	0.23	610.40	38.41	7043.50	20.56	21.73	15.70
2.	MAXHEALTH	994.00	66.40	96743.68	0.20	322.96	4.87	2366.17	16.70	14.97	25.29
3.	MANIPALHOS	709.15	104.54	93279.97	0.00	2434.30	—	30906.30	—	13.93	23.83
4.	FORTIS	913.85	65.84	68991.85	0.11	272.80	2.26	2545.03	17.46	14.07	21.28
5.	ASTERDM	762.10	208.45	66430.16	0.00	29.28	-68.70	1310.68	21.60	11.46	19.53
6.	NH	1922.95	48.15	39297.56	0.23	207.27	5.37	2683.63	78.05	16.20	17.43
7.	MEDANTA	1445.50	69.88	38865.42	0.03	157.25	-1.09	1304.05	26.50	19.38	21.99
8.	LALPATHLAB	1913.55	59.27	32118.71	1.07	1705.00	1172.39	7977.00	1090.95	29.56	31.03
9.	KIMS	753.40	154.89	31643.29	0.00	37.40	-56.00	1179.50	35.33	11.51	19.03
10.	AGARWALEYE	513.40	109.70	16276.12	0.00	55.02	44.56	614.02	25.97	16.14	27.75
11.	VIJAYA	1480.70	81.34	15250.87	0.14	53.10	37.61	230.98	22.83	30.28	42.66
12.	GAUDIUMIVF	123.70	36.81	900.37	0.00	17.76	175.31	193.77	619.69	50.15	12.51

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2024	Mar 2025	Jun 2025	Dec 2025	Mar 2026	Jun 2026
	14	17	12	14	22	14
	8	9	9	8	11	13
Operating Profit	6	8	4	6	11	2
OPM %	40.00%	49.29%	33.85%	41.16%	50.79%	15.90%
Other Income	0	0	0	0	0	1
Interest	0	0	0	1	1	0
Depreciation	1	0	1	0	1	1
	5	8	3	4	10	2
Tax %	27.71%	19.66%	23.65%	26.67%	19.40%	27.65%
Net Profit	3	6	2	3	8	2
	1	1	0	1	1	0
Equity Capital	31	31	31	31	36	36
Reserves	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	37	44	46	59	62
	23	24	27	31	41
Operating Profit	14	20	19	28	—
OPM %	38	45	42	48	—
Other Income	0	0	0	0	1
Interest	1	0	1	2	3
Depreciation	1	1	2	2	2
	12	18	16	25	19
Tax %	26	26	38	25	23
Net Profit	9	13	10	19	15
EPS	92	134	100	3	—
Dividend Payout %	0	48	0	0	—
Minority Interest	0	0	0	0	0
Share of Associates	0	0	0	0	0
Adjusted EPS	1	2	2	3	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 17%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 27%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 58%
Last Year:: 52%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-	-
Equity Capital	1	1	1	31
	9	22	26	15
	3	8	14	17
Trade Payables	1	1	1	1
	6	4	9	11
Total Liabilities	21	35	51	75
ASSETS	-	-	-	-
	4	16	18	18
	0	1	1	6
	0	1	2	3
	0	0	14	24
Cash & Bank	2	15	12	7
	15	2	4	18
Total Assets	21	35	51	75
Total Debt	6	10	16	19
Net Working Capital	8	8	9	14
Contingent Liabilities	0	0	0	0
Book Value per Share	96.61	230.56	269.26	7.40
Face Value	10.00	10.00	10.00	5.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	0	24	3	8
Cash from Investing	0	-14	-5	-15
Cash from Financing	0	4	-1	2
	0	13	-3	-5
Free Cash Flow	0	11	3	7
OCF / Net Profit	0.00	1.81	0.35	0.45
Cumulative 5-Year FCF	0	0	0	0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	91.91	133.94	100.26	3.03
Book Value (₹)	96.61	230.56	269.26	7.40
Dividend per Share (₹)	0.00	64.13	0.00	0.00
Cash EPS (₹)	1.64	2.39	1.96	3.36
PROFITABILITY
Operating Margin %	37.80%	44.99%	41.12%	47.62%
Net Margin %	24.92%	30.13%	21.61%	31.50%
ROE %	95.13%	81.88%	40.12%	51.56%
ROCE %	82.70%	76.47%	45.41%	49.31%
	44.23%	47.72%	23.14%	29.56%
EFFICIENCY
Debtor Days	63	30	58	115
Inventory Days	3	7	12	13
Payable Days	114	91	91	83
	-48	-53	-21	45
FINANCIAL HEALTH
Debt to Equity (x)	0.62x	0.43x	0.59x	0.42x
Interest Coverage (x)	22.93x	41.58x	18.99x	16.20x
	1.85x	1.86x	1.45x	1.56x
GROWTH
Revenue Growth %	0.00%	20.52%	4.37%	28.44%
Operating Profit Growth %	0.00%	43.45%	-3.30%	47.97%
Net Profit Growth %	0.00%	45.73%	-25.15%	87.23%
	0.00%	0.00%	-25.15%	-96.98%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.26x	1.51x

Shareholding Pattern

Numbers in percentages

	Feb 2026	Mar 2026	Jun 2026
	71.29	71.29	71.29
	9.24	6.70	3.01
	5.01	2.63	2.22
Government	0.00	0.00	0.00
	14.26	19.39	23.47

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Updates

2026-09-03 - Gaudium IVF and Women Health Limited has informed the Exchange regarding 'Letter Shareholders providing the weblink and navigation path for accessing the Annual Report for the Financial Year 2025-26 pursuant to Regulation 36(1)(b) of Listing Regulations.'

2026-09-03

Shareholders meeting

2026-09-03 - Gaudium IVF and Women Health Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026

2026-09-01

Copy of Newspaper Publication

2026-09-01 - Gaudium IVF and Women Health Limited has informed the Exchange about Copy of Newspaper Publication regarding Pre-AGM Notice of 11th Annual General Meeting to be on Monday, September 28, 2026, through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).

2026-08-19

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-19 - Gaudium IVF and Women Health Limited has informed the Exchange about Transcript of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

2026-08-14

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about Audio recording of the Earnings Call on the Financial Results for the quarter ended June 30, 2026.

2026-08-14

Copy of Newspaper Publication

2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about the Newspaper publication of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

2026-08-14

Investor Presentation

2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation

2026-08-13

Investor Presentation

2026-08-13 - Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation

2026-08-13

Monitoring Agency Report

2026-08-13 - Monitoring Agency Report for quarter ended June 30, 2026.

News

Recent coverage and analyst commentary for GAUDIUMIVF

Loading news…

🤖

AI Stock Analyst

Gaudium IVF and Women Health Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

APOLLOHOSP

8715.00

59.97

125308.33

0.23

610.40

38.41

7043.50

20.56

21.73

15.70

MAXHEALTH

994.00

66.40

96743.68

0.20

322.96

4.87

2366.17

16.70

14.97

25.29

MANIPALHOS

709.15

104.54

93279.97

0.00

2434.30

—

30906.30

—

13.93

23.83

FORTIS

913.85

65.84

68991.85

0.11

272.80

2.26

2545.03

17.46

14.07

21.28

ASTERDM

762.10

208.45

66430.16

0.00

29.28

-68.70

1310.68

21.60

11.46

19.53

1922.95

48.15

39297.56

0.23

207.27

5.37

2683.63

78.05

16.20

17.43

MEDANTA

1445.50

69.88

38865.42

0.03

157.25

-1.09

1304.05

26.50

19.38

21.99

LALPATHLAB

1913.55

59.27

32118.71

1.07

1705.00

1172.39

7977.00

1090.95

29.56

31.03

KIMS

753.40

154.89

31643.29

0.00

37.40

-56.00

1179.50

35.33

11.51

19.03

AGARWALEYE

513.40

109.70

16276.12

0.00

55.02

44.56

614.02

25.97

16.14

27.75

VIJAYA

1480.70

81.34

15250.87

0.14

53.10

37.61

230.98

22.83

30.28

42.66

GAUDIUMIVF

123.70

36.81

900.37

0.00

17.76

175.31

193.77

619.69

50.15

12.51

Dec 2024

Mar 2025

Jun 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

OPM %

40.00%

49.29%

33.85%

41.16%

50.79%

15.90%

Other Income

Interest

Depreciation

Tax %

27.71%

19.66%

23.65%

26.67%

19.40%

27.65%

Net Profit

Equity Capital

Reserves

Promoter Pledge %

0.00%

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

Operating Profit

—

OPM %

—

Other Income

Interest

Depreciation

Tax %

Net Profit

EPS

134

100

—

Dividend Payout %

—

Minority Interest

Share of Associates

Adjusted EPS

—

Mar 2022

Mar 2023

Mar 2024

Mar 2025

LIABILITIES

Equity Capital

Trade Payables

Total Liabilities

ASSETS

Cash & Bank

Total Assets

Total Debt

Net Working Capital

Contingent Liabilities

Book Value per Share

96.61

230.56

269.26

7.40

Face Value

10.00

5.00

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Cash from Investing

-14

-5

-15

Cash from Financing

-1

-3

-5

Free Cash Flow

OCF / Net Profit

0.00

1.81

0.35

0.45

Cumulative 5-Year FCF

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

91.91

133.94

100.26

3.03

Book Value (₹)

96.61

230.56

269.26

7.40

Dividend per Share (₹)

0.00

64.13

0.00

Cash EPS (₹)

1.64

2.39

1.96

3.36

PROFITABILITY

Operating Margin %

37.80%

44.99%

41.12%

47.62%

Net Margin %

24.92%

30.13%

21.61%

31.50%

ROE %

95.13%

81.88%

40.12%

51.56%

ROCE %

82.70%

76.47%

45.41%

49.31%

44.23%

47.72%

23.14%

29.56%

EFFICIENCY

Debtor Days

115

Inventory Days

Payable Days

114

-48

-53

-21

FINANCIAL HEALTH

Debt to Equity (x)

0.62x

0.43x

0.59x

0.42x

Interest Coverage (x)

22.93x

41.58x

18.99x

16.20x

1.85x

1.86x

1.45x

1.56x

GROWTH

Revenue Growth %

0.00%

20.52%

4.37%

28.44%

Operating Profit Growth %

0.00%

43.45%

-3.30%

47.97%

Net Profit Growth %

0.00%

45.73%

-25.15%

87.23%

0.00%

-25.15%

-96.98%

VALUATION

P/E (x)

0.00x

P/B (x)

0.00x

Dividend Yield %

0.00%

0.00x

0.26x

1.51x

Feb 2026

Mar 2026

Jun 2026

71.29

9.24

6.70

3.01

5.01

2.63

2.22

Government

0.00

14.26

19.39

23.47

Gaudium IVF and Women Health Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Gaudium IVF and Women Health Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI